Rajasthan govt set to revive Rajasthan Drugs and Pharma

Jaipur:  The government of Rajasthan is set to revive Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) based in the state. RDPL is jointly owned by the Central government, which holds a 51% equity stake, and the Rajasthan state government, which owns the remaining 49%.

The decision to revive RDPL was announced earlier in the budget, and the Department of Medical and Health has begun follow-up measures. As part of this effort, Neha Giri, Managing Director of Rajasthan Medical Services Corporation Limited (RMSCL), recently conducted an inspection of the RDPL.

During the inspection, Giri was accompanied by RDPL’s Special Officer and other officials of the corporation, as per UNI.

She inspected the production area, quality control, storage facilities, main building, and campus of RDPL. She was informed that RDPL is located in an industrial area with approximately 10 acres of land under its possession.

Giri inspected the machines and equipment installed at the RDPL campus and assessed their functionality. She directed the RDPL representative to provide information about the company’s building, equipment, and all liabilities. She also sought information about the pending court cases related to RDPL and gave the necessary instructions.

The MD directed that a report be prepared on the 2016 fire incident at RDPL, as well as a compilation of information about the board of directors, currently employed staff, financial provisions, and all liabilities. She also inspected the water supply, electricity supply, biomedical waste, and designated storage areas within the RDPL campus.

Related Posts

After two years, pharma volumes pick up pace

NEW DELHI: The domestic pharmaceutical retail market is showing its strongest signs yet of a shift from price-led to demand-led growth. Volume growth crossed 3% in June, the first time…

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

The National Pharmaceutical Pricing Authority (NPPA) has allowed an increase in the retail price of anti-rabies immunoglobulin while fixing the retail prices of 39 drug formulations.  According to a gazette…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

After two years, pharma volumes pick up pace

After two years, pharma volumes pick up pace

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

NPPA fixes prices of 39 drugs, raises anti-rabies immunoglobulin rate

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Tambaram police arrest two persons after seizing 1,100 banned tablets, 5 kg ganja

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Rajasthan Healthcare Crisis: 8 Mothers Die Post-C-Section

Steroid cream misuse fuels spurt in fungal infections

Steroid cream misuse fuels spurt in fungal infections

Dr Reddy’s delays semaglutide supplies due to API issue

Dr Reddy’s delays semaglutide supplies due to API issue